1. Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML. (1st August 2015) Authors: Mason, Neil T.; Bell, Gillian C.; Quilitz, Rod E.; Greene, John N.; McLeod, Howard L. Journal: Journal of antimicrobial chemotherapy Issue: Volume 70:Number 11(2015:Nov.) Page Start: 3124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prospective CYP2C19‐Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations. Issue 3 (1st November 2019) Authors: Hicks, J. Kevin; Quilitz, Rod E.; Komrokji, Rami S.; Kubal, Timothy E.; Lancet, Jeffrey E.; Pasikhova, Yanina; Qin, Dahui; So, Wonhee; Caceres, Gisela; Kelly, Kerry; Salchert, Yasmina S.; Shahbazian, Kevin; Abbas‐Aghababazadeh, Farnoosh; Fridley, Brooke L.; Velez, Ana P.; McLeod, Howard L.; Green... Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 3(2020) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗